Clinical Trials Logo

Clinical Trial Summary

This study is a single center, open-label, two-part study to assess image guided surgery of intramolecular imaging in nervous system tumors. Subjects with a diagnosis of a resectable nervous system tumor who are at risk of recurrence are included. The primary goal is to observe what tissues fluoresce in the OR, and then to identify if that tissue is cancerous/tumor or normal when the histopathology is performed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02710240
Study type Interventional
Source Abramson Cancer Center of the University of Pennsylvania
Contact
Status Completed
Phase Phase 1/Phase 2
Start date June 10, 2015
Completion date April 2, 2020